Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Aung M. Tun, Seth Maliske, Yucai Wang, David James Inwards, Thomas M. Habermann, Ivana Micallef, Luis Porrata, Jonas Paludo, J. C. Villasboas, Allison C. Rosenthal, Mohamed A. Kharfan-Dabaja, Stephen M Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B Johnston

Blood (2023) 142 (Supplement 1): 2216.

https://doi.org/10.1182/blood-2023-185002

Published: 2023

Journal Articles

Treatment Pattern and Survival Outcome of Limited Stage Mantle Cell Lymphoma: A National Cancer Database Analysis in Pre-BTK Inhibitor Vs BTK Inhibitor Era

Jihao Zhou, Jacqueline F. Wang, Steven Ray Hwang, Jonas Paludo, Javier L. Munoz, David James Inwards, Allison C. Rosenthal, William Breen, Scott Lester, Stephen M Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, Yucai Wang

Blood (2023) 142 (Supplement 1): 1666.

https://doi.org/10.1182/blood-2023-177790

Published: 2023

Journal Articles

Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

James Nathan Gerson, MD, Stefan Klaus Barta, MDMRCP,MS, Diego Villa, Alina S Gerrie, MD, Shaoying Li, MD, Jeffrey Medeiros, MD, Michael Wang, MD, Brian T. Hill, MD PhD, Yazeed Sawalha, MD, Francisco J. Hernandez-Ilizaliturri, MD, Shalin Kothari, MD, Julie M Vose, MD, Timothy S. Fenske, MD, Swapna Narayana Rao, MD, Kami J. Maddocks, MD, David A Bond, MD, Frederick Lansigan, MD, Timothy Burns, MD, Alexandra M Donovan, MD, Amitkumar Mehta, MD, Nishitha Reddy, MD MSCI, MBBS, Daniel J. Landsburg, MD, Martha Glenn, MD, David James Inwards, MD, Kay Ristow, Reem Karmali, MD MS, Jason Kaplan, MD, Elvira Umyarova, MD, Bhargavi Pulluri, MD, Jennifer E Amengual, MD, Jennifer Kimberly Lue, MD, Paolo Caimi, MD, Jonathon B Cohen, MDMS, Oscar Calzada, BS, Elizabeth Handorf, Jennifer Kelly Anderson, MD, Parv Chapani, Veronika Bachanova, MD PhD, Saurabh Rajguru, MD, Michael C Churnetski, BS, Catherine Diefenbach, Martin Bast, Alexandra E. Kovach, MD

Blood (2017) 130 (Supplement 1): 341.

https://doi.org/10.1182/blood.V130.Suppl_1.341.341

Published: 2017

Journal Articles

Vitamin D Insufficiency Is Associated with an Increased Risk of Early Clinical Failure in Follicular Lymphoma

Sean I. Tracy, MD PhD, Matthew J Maurer, MS, Thomas E. Witzig, MD, Matthew T. Drake, MD PhD, Stephen Ansell, MD PhD, Grzegorz S. Nowakowski, MD, David James Inwards, MD, Carrie A Thompson, MD, Patrick B. Johnston, MD PhD, Ivana Micallef, MD, Cristine Allmer, BS, William R. Macon, MD, George J Weiner, MD, Susan L. Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, James R Cerhan, MD PhD

Blood (2016) 128 (22): 1104.

https://doi.org/10.1182/blood.V128.22.1104.1104

Published: 2016

Journal Articles

Sustained Natural Killer Cell Recovery Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation Predicts Survival in Non-Hodgkin's Lymphoma

Luis Porrata, MD, David James Inwards, MD, Stephen M Ansell, MD, PhD, Ivana Micallef, MD, Patrick B. Johnston, MD PhD, Wendy Nevala, Svetomir Markovic, MD PhD

Blood (2016) 128 (22): 4641.

https://doi.org/10.1182/blood.V128.22.4641.4641

Published: 2016

Journal Articles

Cardiac Outcomes in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Carrie A. Thompson, MD, Hongxiu Luo, Matthew J Maurer, MS, Cristine Allmer, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, David James Inwards, MD, Patrick B. Johnston, Luis F. Porrata, MD, Thomas E. Witzig, MD, Veronique Roger, MD, James R Cerhan, MD, PhD

Blood (2011) 118 (21): 2656.

https://doi.org/10.1182/blood.V118.21.2656.2656

Published: 2011

Journal Articles

Phase I Trial of a Novel Combination of An HDAC Inhibitor (LBH589) and An mTOR Inhibitor (RAD001) in Lymphoid and Plasma Cell Malignancies

Shaji Kumar, MD, Joseph R. Mikhael, MD, Betsy R. LaPlant, Joseph P. Colgan, MD, David James Inwards, MD, Patrick B. Johnston, Kristina Laumann, Ivana N. Micallef, MD, Grzegorz S. Nowakowski, Stephen M. Ansell, M.D., Ph.D., Kelly Curtis, MD, Angela Dispenzieri, MD, Martha Q Lacy, MD, Jose F. Leis, MD, PhD, Donald Northfelt, MD, Craig B. Reeder, MD, James L. Slack, MD, Thomas E. Witzig, MD

Blood (2011) 118 (21): 2682.

https://doi.org/10.1182/blood.V118.21.2682.2682

Published: 2011

Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Cell of Origin in Predicting Survival in Diffuse Large B-Cell Lymphoma,

Luis F. Porrata, MD, Kay M. Ristow, Joseph P. Colgan, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, David James Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2011) 118 (21): 3652.

https://doi.org/10.1182/blood.V118.21.3652.3652

Published: 2011

Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Blood (2011) 118 (21): 3642.

https://doi.org/10.1182/blood.V118.21.3642.3642

Published: 2011

Journal Articles

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Wei Ding, MD, PhD, Tait D. Shanafelt, MD, Kari Rabe, MS, Timothy G. Call, MD, Clive S. Zent, MD, Neil Kay, MD, David James Inwards, MD, Deborah Bowen, Mark R. Litzow, MD, Susan L Slager, PhD, Susan Schwager, William J Hogan, MBBCh

Blood (2011) 118 (21): 4152.

https://doi.org/10.1182/blood.V118.21.4152.4152

Published: 2011

Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

Stephen M. Ansell, MD, PhD, Matthew J Maurer, MS, Steven C. Ziesmer, Susan L Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, Thomas E. Witzig, MD, David James Inwards, MD, Joseph P. Colgan, MD, James R Cerhan, MD, PhD, Anne J. Novak, Ph.D.

Blood (2011) 118 (21): 429.

https://doi.org/10.1182/blood.V118.21.429.429

Published: 2011

Journal Articles

A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Martha Q Lacy, MD, Kristina Laumann, Betsy R. LaPlant, Shaji Kumar, MD, Francis K Buadi, M.D., Suzanne R. Hayman, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Stephen M Ansell, MD, Dennis A. Gastineau, MD, David James Inwards, MD, Ivana N. Micallef, MD, Luis F. Porrata, MD, Patrick B. Johnston, Mark R. Litzow, MD, Thomas E. Witzig, MD

Blood (2011) 118 (21): 3095.

https://doi.org/10.1182/blood.V118.21.3095.3095

Published: 2011

Journal Articles

Risk of Transformation of Follicular Lymphoma to High Grade Lymphoma After Radioimmunotherapy: A Prospective Observational Single Institutional Experience

Brian L. Burnette, MD, Gregory Wiseman, MD, Thomas M. Habermann, MD, William R Macon, MD, Stephen M. Ansell, MD, PhD, David James Inwards, MD, Ivana N. Micallef, MD, Patrick B. Johnston, Kay M. Ristow, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2011) 118 (21): 1572.

https://doi.org/10.1182/blood.V118.21.1572.1572

Published: 2011

Journal Articles

Prior Rituximab Exposure Does Not Appear to Affect Time to Treatment Failure After Radioimmunotherapy

Brian L. Burnette, MD, Gregory Wiseman, MD, Thomas M. Habermann, MD, Stephen M. Ansell, MD, PhD, Luis F. Porrata, MD, David James Inwards, MD, Patrick B. Johnston, Ivana Micallef, William R Macon, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski

Blood (2011) 118 (21): 1640.

https://doi.org/10.1182/blood.V118.21.1640.1640

Published: 2011

Journal Articles

A Phase II Study of the Farnesyltransferase Inhibitor Tipifarnib Demonstrates Anti-Tumor Activity In Patients with Relapsed and Refractory Lymphomas

Blood (2010) 116 (21): 287.

https://doi.org/10.1182/blood.V116.21.287.287

Published: 2010

Journal Articles

The Absolute Monocyte and Lymphocyte Counts at Diagnosis Predict Survival and Identify High-Risk Patients In Diffuse Large-B-Cell Lymphoma

Ryan A. Wilcox, MD, PhD, Kay Ristow, Thomas M. Habermann, MD, David James Inwards, MD, Ivana Micallef, MD, Patrick B Johnston, MD, PhD, Joseph Colgan, Grzegorz S. Nowakowski, MD, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD, Svetomir Markovic, MD, PhD, Luis Porrata, MD

Blood (2010) 116 (21): 3088.

https://doi.org/10.1182/blood.V116.21.3088.3088

Published: 2010

Journal Articles

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Ivana N Micallef, MD, Joseph Colgan, MD, Thomas M. Habermann, MD, David James Inwards, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Mamta Gupta, Ph.D, Sergei I Syrbu, MD, Paul Kurtin, MD, William Macon, MD, Thomas E. Witzig, MD

Blood (2010) 116 (21): 4136.

https://doi.org/10.1182/blood.V116.21.4136.4136

Published: 2010

Journal Articles

Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes – Single Institution Experience

Grzegorz S. Nowakowski, MD, Kay Ristow, Paul Kurtin, MD, Mark S Allen, Ivana N Micallef, MD, Joseph Colgan, David James Inwards, MD, Ellen McPhail, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, PhD, Carrie A Thompson, MD, Thomas E. Witzig, MD, Thomas M. Habermann, MD

Blood (2010) 116 (21): 4168.

https://doi.org/10.1182/blood.V116.21.4168.4168

Published: 2010

Journal Articles

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Morie Abraham A. Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Stephen M. Ansell, MD, PhD, Dennis Gastineau, MD, David James Inwards, MD, Patrick B Johnston, MD, PhD, Mark R. Litzow, MD, Ivana Micallef, MD, Luis Porrata, MD, Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3557.

https://doi.org/10.1182/blood.V116.21.3557.3557

Published: 2010

Journal Articles

Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.

Luis F. Porrata, MD, Kay Ristow, Thomas M Haberman, MD, Thomas E Witzig, MD, David James Inwards, MD, Stephen M Ansell, MD, PhD, Patrick B Johnston, MD, PhD, Ivana N. Micallef, MD, Joseph P Colgan, MD, William L White, MD, Svetomir N Markovic, MD, PhD

Blood (2008) 112 (11): 1763.

https://doi.org/10.1182/blood.V112.11.1763.1763

Published: 2008

NARROW

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Treatment Pattern and Survival Outcome of Limited Stage Mantle Cell Lymphoma: A National Cancer Database Analysis in Pre-BTK Inhibitor Vs BTK Inhibitor Era

Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

Vitamin D Insufficiency Is Associated with an Increased Risk of Early Clinical Failure in Follicular Lymphoma

Sustained Natural Killer Cell Recovery Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation Predicts Survival in Non-Hodgkin's Lymphoma

Cardiac Outcomes in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Phase I Trial of a Novel Combination of An HDAC Inhibitor (LBH589) and An mTOR Inhibitor (RAD001) in Lymphoid and Plasma Cell Malignancies

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Cell of Origin in Predicting Survival in Diffuse Large B-Cell Lymphoma,

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

Risk of Transformation of Follicular Lymphoma to High Grade Lymphoma After Radioimmunotherapy: A Prospective Observational Single Institutional Experience

Prior Rituximab Exposure Does Not Appear to Affect Time to Treatment Failure After Radioimmunotherapy

A Phase II Study of the Farnesyltransferase Inhibitor Tipifarnib Demonstrates Anti-Tumor Activity In Patients with Relapsed and Refractory Lymphomas

The Absolute Monocyte and Lymphocyte Counts at Diagnosis Predict Survival and Identify High-Risk Patients In Diffuse Large-B-Cell Lymphoma

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes – Single Institution Experience

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Absolute Lymphocyte Count at the Time of Relapse Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only